Annual ROE
-115.74%
-3.91%-3.50%
31 December 2023
Summary:
Relmada Therapeutics annual return on equity is currently -115.74%, with the most recent change of -3.91% (-3.50%) on 31 December 2023. During the last 3 years, it has fallen by -59.43% (-105.54%). RLMD annual ROE is now -106.02% below its all-time high of 1923.90%, reached on 30 June 2014.RLMD ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-129.80%
-21.22%-19.54%
30 September 2024
Summary:
Relmada Therapeutics quarterly return on equity is currently -129.80%, with the most recent change of -21.22% (-19.54%) on 30 September 2024. Over the past year, it has dropped by -36.43% (-39.02%). RLMD quarterly ROE is now -107.53% below its all-time high of 1724.47%, reached on 30 June 2015.RLMD Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RLMD ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.5% | -39.0% |
| 3 y3 years | -105.5% | -6.0% |
| 5 y5 years | +49.1% | +71.4% |
RLMD ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -105.5% | at low | -65.3% | at low |
| 5 y | 5 years | -1532.4% | +49.1% | -327.1% | +71.4% |
| alltime | all time | -106.0% | +73.1% | -107.5% | +98.5% |
Relmada Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -129.80%(+19.5%) |
| June 2024 | - | -108.58%(+6.4%) |
| Mar 2024 | - | -102.09%(+9.3%) |
| Dec 2023 | -115.74%(+3.5%) | -93.44%(+0.1%) |
| Sept 2023 | - | -93.37%(-1.6%) |
| June 2023 | - | -94.92%(+3.9%) |
| Mar 2023 | - | -91.32%(+3.8%) |
| Dec 2022 | -111.83%(+85.2%) | -87.98%(+12.0%) |
| Sept 2022 | - | -78.52%(-13.8%) |
| June 2022 | - | -91.06%(-6.5%) |
| Mar 2022 | - | -97.44%(-9.2%) |
| Dec 2021 | -60.38%(+7.2%) | -107.26%(-12.4%) |
| Sept 2021 | - | -122.46%(+47.3%) |
| June 2021 | - | -83.15%(+32.1%) |
| Mar 2021 | - | -62.95%(+25.2%) |
| Dec 2020 | -56.31%(+694.2%) | -50.26%(+59.2%) |
| Sept 2020 | - | -31.58%(+3.9%) |
| June 2020 | - | -30.39%(-30.5%) |
| Mar 2020 | - | -43.71%(-90.4%) |
| Dec 2019 | -7.09%(-96.9%) | - |
| Sept 2019 | - | -454.41%(-94.9%) |
| June 2019 | -227.47% | -8864.03%(-1753.4%) |
| Mar 2019 | - | 536.10%(+18.9%) |
| Dec 2018 | - | 450.91%(+57.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | 286.70%(-54.9%) |
| June 2018 | 162.54%(-137.8%) | 635.16%(-129.2%) |
| Mar 2018 | - | -2178.47%(+483.0%) |
| Dec 2017 | - | -373.69%(+72.7%) |
| Sept 2017 | - | -216.40%(+24.9%) |
| June 2017 | -430.49%(+919.2%) | -173.29%(+9.2%) |
| Mar 2017 | - | -158.67%(+39.0%) |
| Dec 2016 | - | -114.18%(+6.4%) |
| Sept 2016 | - | -107.31%(+286.4%) |
| June 2016 | -42.24%(-82.1%) | -27.77%(-148.5%) |
| Mar 2016 | - | 57.25%(-8.6%) |
| Dec 2015 | - | 62.67%(-66.0%) |
| Sept 2015 | - | 184.28%(-89.3%) |
| June 2015 | -236.14%(-112.3%) | 1724.47%(+192.0%) |
| Mar 2015 | - | 590.65%(+30.5%) |
| Dec 2014 | - | 452.70%(+5.0%) |
| Sept 2014 | - | 431.00%(+105.5%) |
| June 2014 | 1923.90%(+485.7%) | - |
| Feb 2014 | - | 209.77%(-32.6%) |
| Nov 2013 | - | 311.11%(-15.2%) |
| Aug 2013 | 328.47%(-409.5%) | 366.85%(-65.3%) |
| May 2013 | - | 1056.41%(-309.5%) |
| Feb 2013 | - | -504.17%(+179.0%) |
| Nov 2012 | - | -180.70%(+77.6%) |
| Aug 2012 | -106.14% | -101.75% |
FAQ
- What is Relmada Therapeutics annual return on equity?
- What is the all time high annual ROE for Relmada Therapeutics?
- What is Relmada Therapeutics annual ROE year-on-year change?
- What is Relmada Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly ROE year-on-year change?
What is Relmada Therapeutics annual return on equity?
The current annual ROE of RLMD is -115.74%
What is the all time high annual ROE for Relmada Therapeutics?
Relmada Therapeutics all-time high annual return on equity is 1923.90%
What is Relmada Therapeutics annual ROE year-on-year change?
Over the past year, RLMD annual return on equity has changed by -3.91% (-3.50%)
What is Relmada Therapeutics quarterly return on equity?
The current quarterly ROE of RLMD is -129.80%
What is the all time high quarterly ROE for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly return on equity is 1724.47%
What is Relmada Therapeutics quarterly ROE year-on-year change?
Over the past year, RLMD quarterly return on equity has changed by -36.43% (-39.02%)